128 related articles for article (PubMed ID: 24926558)
1. To the editor.
Ou SI
J Thorac Oncol; 2014 Jul; 9(7):e57-e58. PubMed ID: 24926558
[No Abstract] [Full Text] [Related]
2. In response.
Shi Y; Yang PC
J Thorac Oncol; 2014 Jul; 9(7):e58-e59. PubMed ID: 24926559
[No Abstract] [Full Text] [Related]
3. EGFR mutations in Asian patients with advanced lung adenocarcinoma.
Liam CK; Pang YK; Poh ME
J Thorac Oncol; 2014 Sep; 9(9):e70-1. PubMed ID: 25122441
[No Abstract] [Full Text] [Related]
4. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Shi Y; Au JS; Thongprasert S; Srinivasan S; Tsai CM; Khoa MT; Heeroma K; Itoh Y; Cornelio G; Yang PC
J Thorac Oncol; 2014 Feb; 9(2):154-62. PubMed ID: 24419411
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
Gao J; Chen JQ; Zhang L; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
Nakano H; Soda H; Takasu M; Tomonaga N; Yamaguchi H; Nakatomi K; Fujino S; Hayashi T; Nakamura Y; Tsukamoto K; Kohno S
Lung Cancer; 2008 Apr; 60(1):136-140. PubMed ID: 17889960
[TBL] [Abstract][Full Text] [Related]
8. Targeting targeted therapy.
Green MR
N Engl J Med; 2004 May; 350(21):2191-3. PubMed ID: 15118072
[No Abstract] [Full Text] [Related]
9. Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer.
Prudkin L; Tang X; Wistuba II
J Thorac Oncol; 2009 Jan; 4(1):139-41. PubMed ID: 19096324
[No Abstract] [Full Text] [Related]
10. Bronchioloalveolar carcinoma: a translational perspective.
Saintigny P; Wistuba II; Kim ES
Oncology (Williston Park); 2010 Sep; 24(10):907-8, 914. PubMed ID: 21138171
[No Abstract] [Full Text] [Related]
11. Epidermal growth factor receptor mutations in Japanese men with lung adenocarcinomas.
Tomita M; Ayabe T; Chosa E; Kawagoe K; Nakamura K
Asian Pac J Cancer Prev; 2014; 15(24):10627-30. PubMed ID: 25605150
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
Ludovini V; Gori S; Pistola L; Della Fazia MA; Piobbico D; Servillo G; Flacco A; Scuderi C; Crinò L
J Thorac Oncol; 2008 Apr; 3(4):452-3. PubMed ID: 18379371
[No Abstract] [Full Text] [Related]
13. BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
Karachaliou N; Costa C; Gimenez-Capitan A; Molina-Vila MA; Bertran-Alamillo J; Mayo C; Massuti B; Majem M; Carcereny E; Moran T; Sanchez JJ; Viteri S; Gasco A; Wannesson L; Souglakos J; Jimeno J; Rosell R;
J Thorac Oncol; 2013 Mar; 8(3):295-300. PubMed ID: 23407556
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.
Zhou Y; Yang Y; Yang C; Chen Y; Yang C; Du Y; Zhao G; Guo Y; Ye L; Huang Y
Oncotarget; 2017 Feb; 8(9):15023-15033. PubMed ID: 28107191
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices.
De Mello RA; Araújo A
Clinics (Sao Paulo); 2012 Nov; 67(11):1349. PubMed ID: 23184216
[No Abstract] [Full Text] [Related]
16. Clinical outcomes and prognostic factors associated with the response to erlotinib in non-small-cell lung cancer patients with unknown EGFR mutational status.
Aydiner A; Yildiz I; Seyidova A
Asian Pac J Cancer Prev; 2013; 14(5):3255-61. PubMed ID: 23803112
[TBL] [Abstract][Full Text] [Related]
17. Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.
Thomas A; Xi L; Carter CA; Rajan A; Khozin S; Szabo E; Dennis PA; Giaccone G; Raffeld M
Clin Lung Cancer; 2013 Jul; 14(4):452-6. PubMed ID: 23540867
[No Abstract] [Full Text] [Related]
18. Frequency of EGFR mutations in non-small cell lung cancer patients: screening data from West Siberia.
Gervas P; Ivanova A; Vasiliev N; Ananina O; Zharkova O; Rogovieva O; Verzhbitskaya N; Didichuk I; Cheremisina O; Popova N; Goldberg V; Cherdyntsev E; Choynzonov E; Cherdyntseva N
Asian Pac J Cancer Prev; 2015; 16(2):689-92. PubMed ID: 25684509
[TBL] [Abstract][Full Text] [Related]
19. Limitations of single-strand conformation polymorphism analysis as a high-throughput method for the detection of EGFR mutations in the clinical setting.
Weber F; Fukino K; Villalona-Calero M; Eng C
J Clin Oncol; 2005 Aug; 23(24):5847-8; author reply 5848-9. PubMed ID: 16110042
[No Abstract] [Full Text] [Related]
20. K-ras mutations in lung cancer: the "mysterious mutation".
Hirsch FR
Clin Lung Cancer; 2006 Jul; 8(1):11-2. PubMed ID: 16870039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
